Cleared Traditional

ELECSYS PSA, MODEL 2010

K982949 · Boehringer Mannheim Corp. · Immunology
Oct 1998
Decision
67d
Days
Class 2
Risk

About This 510(k) Submission

K982949 is an FDA 510(k) clearance for the ELECSYS PSA, MODEL 2010, a Prostate-specific Antigen (psa) For Management Of Prostate Cancers (Class II — Special Controls, product code LTJ), submitted by Boehringer Mannheim Corp. (Indianapolis,, US). The FDA issued a Cleared decision on October 27, 1998, 67 days after receiving the submission on August 21, 1998. This device falls under the Immunology review panel. Regulated under 21 CFR 866.6010.

Submission Details

510(k) Number K982949 FDA.gov
FDA Decision Cleared SESE
Date Received August 21, 1998
Decision Date October 27, 1998
Days to Decision 67 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code LTJ — Prostate-specific Antigen (psa) For Management Of Prostate Cancers
Device Class Class II — Special Controls
CFR Regulation 21 CFR 866.6010

Similar Devices — LTJ Prostate-specific Antigen (psa) For Management Of Prostate Cancers

All 33
Atellica IM Total PSA II (tPSAII)
K251630 · Siemens Healthcare Diagnostics, Inc. · Jan 2026
FREND PSA PLUS (reagent cartridge)
K162378 · Nanoentek USA, Inc. · May 2017
FREND PSA PLUS (REAGENT CARTRIDGE)
K124056 · Nanoentek, Inc. · May 2013
TPSA FLEX REAGENT CARTRIDGE
K031343 · Dade Behring, Inc. · May 2003
PROSTATE SPECIFIC ANTIGEN (PSA) ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEM
K022177 · Bayer Diagnostics Corp. · Dec 2002
COMPLEXED PROSTATE SPECIFIC ANTIGEN (CPSA) ASSAY FOR THE BAYER ADVIA INTEGRATED MODULE SYSTEM
K022288 · Bayer Corp. · Dec 2002